Cite
MLA Citation
Mayan Gilboa et al.. “Early Immunogenicity and Safety of the Third Dose of BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Among Adults Older Than 60 Years: Real-World Experience.” Journal of infectious diseases, vol. 225, 2022, pp. 785–792. http://access.bl.uk/ark:/81055/vdc_100151266693.0x00003f